Study of Serum Amylin Level in Impaired Glucose Tolerance Subjects

The aim of study was to measure serum level of amylin in impaired glucose tolerance subjects and compare with healthy control subjects. In this study 160 IGT and 160 healthy subjects (age and gender matched) were enrolled. BMI, Glucose, HOMA IR, Insulin and amylin were assessed. Serum amylin levels were higher in impaired glucose tolerance subjects compared with healthy controls (7.4±2.7 pmol/l vs 4.0± 0.6 pmol/l, respectively, Pless than0.0001). Increased levels of amylin can assess diabetes at an early stage.